VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
ORAL7® Mouthwash
Preclinical
M
MBD MARKETING SDN. BHD.
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[2]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Third Molar
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Third Molar
Preclinical
Completed
Clinical
Trials by Indication
[1]
Third Molar
1 trial
The Effects of Natural Enzyme-Containing Mouthwash in Wound Healing After Surgical Removal of Impacted Mandibular Third Molar
Completed
·
M
MBD MARKETING SDN. BHD.
·
Preclinical
·
NCT07627945
·
58 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for ORAL7® Mouthwash. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform
—
Drug–disease associations for ORAL7® Mouthwash. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR
—
MBD MARKETING SDN. BHD. company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Highest Phase
Preclinical
[1]
Company
M
MBD MARKETING SDN. BHD.
Related News